Cultural Thesis Scan
Scan
Cultural Thesis Scan
raw scan snapshot — prices as of scan date, not live 20 rows · screens, not recommendations
The cultural consumer basket is in severe distress: BRBR collapsed -86% from 52wk high, LULU -54%, NKE -44%, DPZ -35% — the only constructive names are CROX (RSI 68, +60% 3M) and HIMS (RSI 63.3, +41% 30D), both recovering from prior deep drawdowns; TSLA and SBUX are range-bound.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🔴 Broadly weak — four names in structural downtrend; two in active recovery; cohort is a split between cultural collapse and GLP-1/wellness resurgence |
| Recovery leaders | CROX (RSI 68.0, +60% 3M, near 52wk high -2%), HIMS (RSI 63.3, +41% 30D, +26% 3M) |
| Deep oversold | LULU (RSI 35.7, -54.2% from 52wk high, -27.5% 3M), BRBR (RSI 38.6, -86% from 52wk high, -52.3% 3M) |
| Range-bound | TSLA (RSI 48.1, -18.9% from 52wk high), SBUX (RSI 54.0, -6.6% from 52wk high) |
| Key insight | HIMS has a death cross but RSI 63.3 and +41% 30D — the telehealth/GLP-1 recovery is real but the technical structure is still recovering; BRBR at $8.83 (-86% from high) requires thesis verification before any interest |
Price Table
| Stock | Price | RSI | vs SMA20 | 7D% | 30D% | Signal |
|---|---|---|---|---|---|---|
| BRBR | $8.83 | 38.6 | +1.0% | +7.65% | -4.64% | ❌ Don't Buy |
| HIMS | $31.47 | 63.3 | +18.3% | +5.19% | +41.18% | ⚠️ Caution |
| NKE | $45.04 | 52.6 | +1.2% | +0.11% | +6.76% | 🔍 Watch |
| LULU | $115.50 | 35.7 | -6.6% | -3.53% | -3.96% | 🔍 Watch |
| SBUX | $101.68 | 54.0 | +1.7% | +3.62% | -4.62% | 🔒 Hold |
| CROX | $127.08 | 68.0 | +7.6% | -2.09% | +31.01% | ⚠️ Caution |
| DPZ | $320.51 | 52.3 | +2.7% | -0.22% | +4.70% | 🔍 Watch |
| TSLA | $404.66 | 48.1 | -2.5% | +0.93% | -1.30% | 🔍 Watch |
Tier Analysis
RSI < 25 — Extreme Oversold
None.
RSI 25–40 — Approaching Oversold / Watch
- LULU (RSI 35.7, $115.50, -6.6% below SMA20, -27.5% 3M, strong-down, death cross, -54.2% from 52wk high) — lululemon. Multi-year leader in full breakdown. Death cross + strong-down = do not catch knife. Thesis needs re-evaluation: China slowdown + post-pandemic athleisure saturation.
- BRBR (RSI 38.6, $8.83, +1.0% above SMA20, -52.3% 3M, strong-down, death cross, -86.0% from 52wk high) — BellRing Brands (protein shakes). Catastrophic collapse; -86% from 52wk high is value trap territory. Avoid without clear thesis reset — GLP-1 headwind on protein supplement demand.
RSI 40–60 — Neutral / Consolidating
- NKE (RSI 52.6, $45.04, +1.2% above SMA20, +6.8% 30D, weak-up, death cross, -43.8% from 52wk high) — Nike. Bouncing slightly; -22.6% 1Y. Execution turnaround is a multi-year story not a trade.
- DPZ (RSI 52.3, $320.51, +2.7% above SMA20, -18.6% 3M, strong-down, death cross, -35.4% from 52wk high) — Domino's Pizza. Flat 30D recovery within an ongoing downtrend; QSR value proposition intact but price power uncertain.
- TSLA (RSI 48.1, $404.66, -2.5% below SMA20, weak-up, death cross, -18.9% from 52wk high) — Tesla. Range-bound; +0.9% 7D, -1.3% 30D. Cultural sentiment proxy; no momentum signal.
- ADM/SBUX (RSI 54.0, $101.68, +1.7% above SMA20, strong-up, +11.9% above SMA200) — Starbucks. Only name in the cohort with a strong-up trend. Niccol turnaround is showing early signs; -6.6% from 52wk high. Near-term support at SMA20.
RSI 60+ — Recovery / Overbought Watch
- HIMS (RSI 63.3, $31.47, +18.3% above SMA20, +41.2% 30D, weak-up, death cross, -55.3% from 52wk high) — Hims & Hers. The GLP-1 compounding tailwind is showing up in price: +41% 30D but the death cross + -55% from 52wk high means the recovery has a long way to prove itself. Caution on new entries after this move.
- CROX (RSI 68.0, $127.08, +7.6% above SMA20, +31% 30D, +60% 3M, strong-up, -2% from 52wk high) — Crocs. The breakout cultural consumer of the cohort. Near 52wk high; RSI approaching overbought. Hold if in; do not chase at RSI 68 within 2% of highs.
Entry Zones
| Stock | Price | Zone | RSI | 30D% | Setup |
|---|---|---|---|---|---|
| SBUX | $101.68 | $96–104 | 54.0 | -4.62% | Only strong-up trend in cohort; Niccol turnaround; pull to SMA20 = entry zone |
| NKE | $45.04 | watch $42–46 | 52.6 | +6.76% | Recovery bounce forming; do NOT buy ahead of evidence — weak-up within death cross; -43.8% from 52wk high |
| LULU | $115.50 | wait | 35.7 | -3.96% | Approaching oversold but strong-down; only consider below $105 with clear base after death cross resolves |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| ⚠️ CAUTION | CROX (RSI 68, -2% from 52wk high), HIMS (+41% 30D, death cross) | Don't chase; trim strength; CROX near highs, HIMS needs more base-building |
| 🔒 HOLD | SBUX | Only strong-up trend + Niccol catalyst; stay the course |
| 🔍 WATCH | NKE, DPZ, TSLA, LULU | Various — NKE/DPZ need execution evidence; TSLA range-bound; LULU too early |
| ❌ DON'T BUY | BRBR, LULU (now) | BRBR -86% from high with death cross; LULU strong-down — falling knives until trend inflects |
What Changed
- CROX is the standout cultural winner — +60% 3M, near 52wk high, RSI 68. Ergonomic/comfort casualwear thesis working while fashion-athletic (LULU/NKE) collapses.
- HIMS recovering on GLP-1 tailwind — +41% 30D; but down -55% from 52wk high with death cross; partial recovery not full vindication.
- BRBR collapsed further — was already weak; now -86% from 52wk high. GLP-1 headwinds on protein supplement demand are real.
- LULU deepened — -27.5% 3M, -54.2% from 52wk high. Former high-multiple premium athleisure brand under severe pressure.
- SBUX is the only constructive name — strong-up trend, Niccol turnaround thesis early innings; only member with confirmed golden cross.
- TSLA cultural proxy remains range-bound — flat 7D/30D; neither Elon brand risk nor AI-vehicle hype has driven a clear directional move.
Related
10 events DateTypeEvent
Jun 20 ScanCultural Thesis Scan Jun 25 ScanCultural Thesis Scan Jun 26 ScanCultural Thesis Scan May 29 ScanCultural Thesis Scan Jul 7 ScanCultural Thesis Scan Jun 25 UpdateSBUX — candidate.roundup Jun 26 UpdateSBUX — candidate.roundup Jul 11 ScanCultural Thesis Scan Jun 16 UpdateConsumer Candidates Jun 16 ScanConsumer Scan No direct external sources are attached to this read.